Your browser doesn't support javascript.
loading
Photosensitizer-based small molecule theranostic agents for tumor-targeted monitoring and phototherapy.
Gao, Jiake; Jiang, Hongfei; Chen, Pengwei; Zhang, Renshuai; Liu, Ning.
Afiliação
  • Gao J; The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266071, China.
  • Jiang H; The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266071, China.
  • Chen P; Hainan Key Laboratory for Research and Development of Natural Products from Li Folk Medicine, Institute of Tropical Bioscience and Biotechnology, Chinese Academy of Tropical Agricultural Sciences, Haikou 571101, China. Electronic address: chenpengwei@itbb.org.cn.
  • Zhang R; The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266071, China. Electronic address: zhangrenshuai@qdu.edu.cn.
  • Liu N; The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266071, China. Electronic address: leirum_ln@qdu.edu.cn.
Bioorg Chem ; 136: 106554, 2023 07.
Article em En | MEDLINE | ID: mdl-37094481
ABSTRACT
Small molecule theranostic agents for tumor treatment exhibited triadic properties in tumor targeting, imaging, and therapy, which have attracted increasing attention as a potential complement for, or improved to, classical small molecule antitumor drugs. Photosensitizer have dual functions of imaging and phototherapy, and have been widely used in the construction of small molecule theranostic agents over the last decade. In this review, we summarized representative agents that have been studied in the field of small molecule theranostic agents based on photosensitizer in the last decade, and highlighted their characteristics and application in tumor-targeted monitoring and phototherapy. The challenges and future perspectives of photosensitizers in building small molecule theranostic agents for diagnosis and therapy of tumors were also discussed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Bioorg Chem Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanopartículas / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Bioorg Chem Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China